Article
[Cancer therapy by PARP inhibitors].
Nihon rinsho. Japanese journal of clinical medicine - 1 Aug 2015
Seimiya Hiroyuki
Abstract excerpt
Poly(ADP-ribose) polymerases(PARP) synthesize the ADP-ribose polymers onto proteins and play a role in DNA repair. PARP inhibitors block the repair of single-strand breaks, which in turn gives rise to double-strand breaks during DNA replication. Thus, PARP inhibitors elicit synthetic lethality in cancer with BRCA1/2 loss-of-function mutations that hamper homologous recombination repair of double-strand breaks....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
